Literature DB >> 16756536

Vulnerable patients with a fractured neck of femur: nutritional status and support in hospital.

M Nematy1, M Hickson, A E Brynes, C H S Ruxton, G S Frost.   

Abstract

BACKGROUND AND AIM: Malnutrition has serious consequences for recovery and increases the risk of complications in hospital patients. Fractured neck of femur (NOF) patients may be particularly at risk because of their old age and frail state of health. We conducted an observational study to evaluate the nutritional state and the nutritional support, which was provided to this group during their stay in hospital.
METHODS: Twenty-five consecutive people admitted to an orthopaedic ward with a fractured NOF at Charing Cross Hospital, London were recruited. Anthropometric measures, biochemical indices, 3 days dietary intake and dietetic referral rates were collected.
RESULTS: Patients had a significantly lower body mass index (BMI) compared with the mean BMI for sex and age in an elderly UK population (21.97 +/- 1.06 versus 26.73 +/- 0.03 kg m(-2); P < 0.005). They took just 58.6% of their energy requirements in hospital (4219 +/- 319 versus 7199 +/- 202 kJ mean(-1) daily intake over 3 days in week 2). Using the hospitals own nutritional risk assessment tool 56% of patients were found to be at risk of malnutrition on admission, which increased to 68% after 2-3 weeks. Of these 64% were referred to a dietitian and were given nutritional supplements. Nutritional assessment revealed that their nutritional status worsened during stay.
CONCLUSIONS: This group of patients with fractured NOF is likely to be malnourished on admission and to show a rapid deterioration in its nutrition status during admission. Energy needs were not met in up to 50% of patients. These results reinforce the need to screen, supplement and monitor fractured NOF patients.

Entities:  

Mesh:

Year:  2006        PMID: 16756536     DOI: 10.1111/j.1365-277X.2006.00692.x

Source DB:  PubMed          Journal:  J Hum Nutr Diet        ISSN: 0952-3871            Impact factor:   3.089


  7 in total

1.  Nutrition Screening Practices amongst Australian Residential Aged Care Facilities.

Authors:  J Kellett; G Kyle; C Itsiopoulos; M Naunton
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

2.  Serum vitamin E concentrations among highly functioning hip fracture patients are higher than in nonfracture controls.

Authors:  Christopher R D'Adamo; Michelle D Shardell; Gregory E Hicks; Denise L Orwig; Marc C Hochberg; Richard D Semba; Janet A Yu-Yahiro; Luigi Ferrucci; Jay S Magaziner; Ram R Miller
Journal:  Nutr Res       Date:  2011-03       Impact factor: 3.315

3.  Advancing Quality (AQ) hip fracture programme: A large scale programme to improve nutritional assessment in people with hip fractures.

Authors:  Benjamin Kapur; Philippa Thorpe
Journal:  J Orthop       Date:  2019-06-10

4.  Effects of Nutritional Status on 6-Month Outcome of Hip Fractures in Elderly Patients.

Authors:  Ka Ying Doris Miu; Pui Shan Lam
Journal:  Ann Rehabil Med       Date:  2017-12-28

5.  Weight changes and mobility in the early phase after hip fracture in community-dwelling older persons.

Authors:  Hanne Rosendahl-Riise; Jutta Dierkes; Svanhild Ådnanes; Vilde Aabel Skodvin; Elin Strand; Anette Hylen Ranhoff
Journal:  Eur Geriatr Med       Date:  2020-06-16       Impact factor: 1.710

6.  Beneficial effects of preoperative oral nutrition supplements on postoperative outcomes in geriatric hip fracture patients: A PRISMA-compliant systematic review and meta-analysis of randomized controlled studies.

Authors:  Wen-Yi Lai; Yu-Chi Chiu; Kuo-Ching Lu; I-Tao Huang; Pei-Shan Tsai; Chun-Jen Huang
Journal:  Medicine (Baltimore)       Date:  2021-11-24       Impact factor: 1.817

Review 7.  Nutritional Status and Nutritional Treatment Are Related to Outcomes and Mortality in Older Adults with Hip Fracture.

Authors:  Vincenzo Malafarina; Jean-Yves Reginster; Sonia Cabrerizo; Olivier Bruyère; John A Kanis; J Alfredo Martinez; M Angeles Zulet
Journal:  Nutrients       Date:  2018-04-30       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.